Astrana Health (NASDAQ:ASTH) Sets New 1-Year Low – Here’s Why

Astrana Health, Inc. (NASDAQ:ASTH)’s share price hit a new 52-week low during mid-day trading on Thursday . The company traded as low as $20.72 and last traded at $22.03, with a volume of 751310 shares changing hands. The stock had previously closed at $21.38.

Wall Street Analyst Weigh In

ASTH has been the subject of several research reports. TD Cowen decreased their price objective on shares of Astrana Health from $40.00 to $35.00 and set a “buy” rating for the company in a report on Monday, November 10th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Astrana Health in a research report on Monday. BTIG Research lowered their price objective on shares of Astrana Health from $50.00 to $45.00 and set a “buy” rating for the company in a report on Friday, November 7th. Finally, Zacks Research cut Astrana Health from a “hold” rating to a “strong sell” rating in a research report on Monday, November 10th. Six research analysts have rated the stock with a Buy rating, two have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $45.29.

Astrana Health Stock Up 3.0%

The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.59 and a current ratio of 1.59. The stock’s 50-day moving average price is $29.11 and its two-hundred day moving average price is $27.41. The stock has a market capitalization of $1.24 billion, a PE ratio of 43.20, a P/E/G ratio of 0.90 and a beta of 0.79.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings results on Wednesday, January 10th. The company reported $0.50 earnings per share (EPS) for the quarter. Astrana Health had a net margin of 1.04% and a return on equity of 3.43%. The company had revenue of $317.00 million during the quarter. As a group, analysts expect that Astrana Health, Inc. will post 1.15 EPS for the current fiscal year.

Institutional Trading of Astrana Health

Several hedge funds and other institutional investors have recently made changes to their positions in ASTH. Covestor Ltd increased its position in Astrana Health by 777.6% during the 1st quarter. Covestor Ltd now owns 2,001 shares of the company’s stock valued at $62,000 after buying an additional 1,773 shares in the last quarter. Tower Research Capital LLC TRC grew its stake in shares of Astrana Health by 323.3% in the second quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock worth $115,000 after acquiring an additional 3,517 shares during the last quarter. State of Wyoming purchased a new stake in shares of Astrana Health in the second quarter worth $132,000. AlphaQuest LLC increased its holdings in shares of Astrana Health by 144.2% during the first quarter. AlphaQuest LLC now owns 4,883 shares of the company’s stock valued at $151,000 after acquiring an additional 2,883 shares in the last quarter. Finally, US Bancorp DE raised its position in shares of Astrana Health by 21.3% in the 1st quarter. US Bancorp DE now owns 5,791 shares of the company’s stock worth $180,000 after purchasing an additional 1,015 shares during the last quarter. Hedge funds and other institutional investors own 52.77% of the company’s stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.